Updated Recommendation
A new evidence synthesis was published:2018, Latent tuberculosis infection: updated and consolidated guidelines for programmatic management
View latest version (2018)Bibliographic Info
Recommendation
Recommended in favor
Strong
Certainty of evidence
Very low
Systematic testing and treatment of latent tuberculosis infection (LTBI) should be performed in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor (TNF) treatment, patients receiving dialysis, patients preparing for organ or haematologic transplantation, and patients with silicosis. Either interferon-gamma release assays (IGRA) or Mantoux tuberculin skin test (TST) should be used to test for latent tuberculosis infection (LTBI).
Also Featured In
This recommendation also appears in the following guidelines:
Latent tuberculosis infection: updated and consolidated guidelines for programmatic management
WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention
WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment, 2nd ed